title: How much do we pay for a benefit? A descriptive cost analysis of the use of statins. The need for a national cost-effectiveness analysis.
authors.affiliation: Instituto de Cardiologia do Rio Grande do Sul/Fundação Universitária de Caridologia, Porto Alegre, RS, Brazil.
authors.forename: J L
authors.initials: JL
authors.lastname: Vieira
authors.forename: V L
authors.initials: VL
authors.lastname: Portal
authors.forename: E H
authors.initials: EH
authors.lastname: Moriguchi
mesh_terms: D000924:Anticholesteremic Agents / Q000191:economics*; D001938:Brazil; D003362:Cost-Benefit Analysis; D006331:Heart Diseases / Q000191:economics* / Q000517:prevention & control; D006801:Humans; D006937:Hypercholesterolemia / Q000191:economics* / Q000517:prevention & control
chemical_list: D000924:Anticholesteremic Agents